Literature DB >> 19752320

Mac-1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury.

Junichi Hirahashi1, Keiichi Hishikawa, Shinya Kaname, Naotake Tsuboi, Yunmei Wang, Daniel I Simon, George Stavrakis, Tatsuo Shimosawa, Ling Xiao, Yutaka Nagahama, Kazuo Suzuki, Toshiro Fujita, Tanya N Mayadas.   

Abstract

BACKGROUND: Inflammation and thrombosis coexist in several disorders. Although it is recognized that leukocytes may induce a procoagulant state at sites of inflammation, the critical molecular determinants of this process remain largely unknown. METHODS AND
RESULTS: To examine mechanisms of inflammation-induced thrombosis, we developed a murine model of thrombotic glomerulonephritis (TGN), a known cause of acute renal failure in patients. This model, induced by lipopolysaccharide and antibody to the glomerular basement membrane, led to rapid glomerular neutrophil recruitment, thrombotic glomerular lesions with endothelial cell injury, and renal dysfunction. In mice immunodepleted of neutrophils or lacking the leukocyte-specific integrin Mac-1, neutrophil recruitment, endothelial injury, glomerular thrombosis, and acute renal failure were markedly attenuated despite the robust generation of renal cytokines. Neutrophil elastase is a likely effector of Mac-1 because its activity was reduced in Mac-1-deficient mice and the phenotype in mice deficient in Mac-1 or neutrophil elastase was similar. Platelets accumulated in glomerular capillaries within 4 hours of TGN before evidence of thrombosis. Platelet immunodepletion before TGN markedly exacerbated hematuria (hemorrhage), inflammation, and injury, whereas thrombocytopenic Mac-1-deficient mice remained resistant to disease, indicating that initial glomerular platelet deposition protects the vessel wall from neutrophil-mediated sequelae. The subsequent thrombosis relied on the interaction of Mac-1 on recruited neutrophils with glycoprotein Ibalpha on platelets as antibody-mediated disruption of this interaction attenuated TGN without affecting renal neutrophil accumulation.
CONCLUSIONS: These observations establish Mac-1 on neutrophils as a critical molecular link between inflammation and thrombosis and suggest it as an attractive target for antithrombotic therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19752320      PMCID: PMC2780001          DOI: 10.1161/CIRCULATIONAHA.109.873695

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  40 in total

1.  Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor.

Authors:  C Weber; T A Springer
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

2.  How do platelets prevent bleeding?

Authors:  Bernhard Nieswandt
Journal:  Blood       Date:  2008-05-15       Impact factor: 22.113

3.  Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura.

Authors:  J A Cohen; M E Brecher; N Bandarenko
Journal:  J Clin Apher       Date:  1998       Impact factor: 2.821

Review 4.  A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders.

Authors:  N Besbas; D Karpman; D Landau; C Loirat; W Proesmans; G Remuzzi; G Rizzoni; C M Taylor; N Van de Kar; L B Zimmerhackl
Journal:  Kidney Int       Date:  2006-06-14       Impact factor: 10.612

5.  A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation.

Authors:  A Coxon; P Rieu; F J Barkalow; S Askari; A H Sharpe; U H von Andrian; M A Arnaout; T N Mayadas
Journal:  Immunity       Date:  1996-12       Impact factor: 31.745

Review 6.  Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura.

Authors:  P Ruggenenti; M Noris; G Remuzzi
Journal:  Kidney Int       Date:  2001-09       Impact factor: 10.612

7.  Neutrophil-mediated endothelial injury in haemolytic uraemic syndrome.

Authors:  K D Forsyth; A C Simpson; M M Fitzpatrick; T M Barratt; R J Levinsky
Journal:  Lancet       Date:  1989-08-19       Impact factor: 79.321

8.  Platelet granule secretion continuously prevents intratumor hemorrhage.

Authors:  Benoit Ho-Tin-Noé; Tobias Goerge; Stephen M Cifuni; Daniel Duerschmied; Denisa D Wagner
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

9.  Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticles.

Authors:  Elzbieta Pluskota; Neil M Woody; Dorota Szpak; Christie M Ballantyne; Dmitry A Soloviev; Daniel I Simon; Edward F Plow
Journal:  Blood       Date:  2008-05-28       Impact factor: 22.113

10.  Low platelet counts alone do not cause bleeding in an experimental immune thrombocytopenic purpura in mice.

Authors:  Victoria Domínguez; Tzipe Govezensky; Goar Gevorkian; Carlos Larralde
Journal:  Haematologica       Date:  2003-06       Impact factor: 9.941

View more
  42 in total

1.  Opening the field of integrin biology to "biased agonism".

Authors:  Daniel I Simon
Journal:  Circ Res       Date:  2011-11-11       Impact factor: 17.367

2.  ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein.

Authors:  Marcia L Moss; Gary Powell; Miles A Miller; Lori Edwards; Bin Qi; Qing-Xiang Amy Sang; Bart De Strooper; Ina Tesseur; Stefan F Lichtenthaler; Mara Taverna; Julia Li Zhong; Colin Dingwall; Taheera Ferdous; Uwe Schlomann; Pei Zhou; Linda G Griffith; Douglas A Lauffenburger; Robert Petrovich; Jörg W Bartsch
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

3.  Macrophage extracellular trap formation promoted by platelet activation is a key mediator of rhabdomyolysis-induced acute kidney injury.

Authors:  Koshu Okubo; Miho Kurosawa; Mako Kamiya; Yasuteru Urano; Akari Suzuki; Kazuhiko Yamamoto; Koji Hase; Koichiro Homma; Junichi Sasaki; Hiroaki Miyauchi; Tatsuo Hoshino; Matsuhiko Hayashi; Tanya N Mayadas; Junichi Hirahashi
Journal:  Nat Med       Date:  2018-01-08       Impact factor: 53.440

4.  Chebulagic acid inhibits the LPS-induced expression of TNF-α and IL-1β in endothelial cells by suppressing MAPK activation.

Authors:  Yueying Liu; Luer Bao; Liying Xuan; Baohua Song; Lin Lin; Hao Han
Journal:  Exp Ther Med       Date:  2015-04-23       Impact factor: 2.447

Review 5.  Endothelium-neutrophil interactions in ANCA-associated diseases.

Authors:  Lise Halbwachs; Philippe Lesavre
Journal:  J Am Soc Nephrol       Date:  2012-09       Impact factor: 10.121

Review 6.  The role of neutrophils and NETosis in autoimmune and renal diseases.

Authors:  Sarthak Gupta; Mariana J Kaplan
Journal:  Nat Rev Nephrol       Date:  2016-05-31       Impact factor: 28.314

7.  Developmental endothelial locus-1 attenuates complement-dependent phagocytosis through inhibition of Mac-1-integrin.

Authors:  Ioannis Mitroulis; Yoon-Young Kang; Carl G Gahmberg; Gabriele Siegert; George Hajishengallis; Triantafyllos Chavakis; Eun-Young Choi
Journal:  Thromb Haemost       Date:  2013-12-19       Impact factor: 5.249

Review 8.  The non-haemostatic role of platelets in systemic lupus erythematosus.

Authors:  Petrus Linge; Paul R Fortin; Christian Lood; Anders A Bengtsson; Eric Boilard
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

9.  A Genetic Model of Constitutively Active Integrin CD11b/CD18.

Authors:  Laisel Martinez; Xiaobo Li; Gioser Ramos-Echazabal; Hafeez Faridi; Zachary M Zigmond; Nieves Santos Falcon; Diana R Hernandez; Serene A Shehadeh; Omaida C Velazquez; Vineet Gupta; Roberto I Vazquez-Padron
Journal:  J Immunol       Date:  2020-09-16       Impact factor: 5.422

10.  Serum-starved adipose-derived stromal cells ameliorate crescentic GN by promoting immunoregulatory macrophages.

Authors:  Kazuhiro Furuhashi; Naotake Tsuboi; Asuka Shimizu; Takayuki Katsuno; Hangsoo Kim; Yosuke Saka; Takenori Ozaki; Yoshikazu Sado; Enyu Imai; Seiichi Matsuo; Shoichi Maruyama
Journal:  J Am Soc Nephrol       Date:  2013-03-07       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.